Finally, multiple datasets revealed significant associations between increased PRL-3 expression in cancerous versus normal tissue, invasive ductal breast carcinoma compared to non-invasive disease, increased tumor grade, stage and development of metastases at 1 and 3 year intervals following diagnosis (Table 2). The gene discussed is PTP4A3; the disease is invasive ductal breast carcinoma.